Trademarkia Logo

Canada

C$
Trademark Search in Canada
GEGANT

View On IC.GC.CA

GEGANT
REGISTRATION PENDING

Last Applicant/ Owned by

ITM Medical Isotopes GmbH

Lichtenbergstr. 1 85748Garching

DE

Serial Number

1966025 filed on 30th May 2019

Correspondent Address

OYEN WIGGS GREEN & MUTALA LLP

480-THE STATION, 601 WEST CORDOVA STREETVANCOUVER

BRITISH COLUMBIA

CA

V6B1G1

GEGANT

Trademark usage description

gallium-68 compounds, including 68-ga chlorides, gallium-68 compounds, including 68-ga peptide chelates, in particular 68-ga-dotatoc and 68-ga-dotatat Read More

Classification Information

Class [001]
Gallium-68 compounds, including 68-Ga chlorides, Gallium-68 compounds, including 68-Ga peptide chelates, in particular 68-Ga-DOTATOC and 68-Ga-DOTATATE, 68-Ga salts, in particular 68-Ga chlorides

Classification kind code

11

Class [005]
Radiopharmaceutical preparations for use in oncology, namely radiopharmaceuticals containing Gallium-68 for treating and diagnosing tumours; Gallium-68 for use in the field of Targeted Radionuclide Therapy to diagnose cancers, in particular prostate cancer and neuroendocrine tumours; Gallium-68 for use as radiotracers in PET scans or combined PET/CT scans.

Classification kind code

11

Class [010]
Ge-68/Ga-68 radionuclide generators for pharmaceutical purposes as source of radionuclides being positron emitters in the field of Positron Emission Tomography - Computed Tomography (PET/CT).

Classification kind code

11

Class [011]
Environmental control items

Comment text

CIPO Classification Code

Classification kind code

Nice

Class [042]
Scientific and technological services and research on radiopharmaceutical products, namely 68-Ga products for use in medicine for third parties, namely services relating to radiopharmaceuticals for the therapy and diagnosis of diseases and services relating to radiopharmaceuticals coupled to somatostatin analogues for the diagnosis and treatment of tumours.

Classification kind code

11

Class [044]
Pharmaceutical advice in relation to radiopharmaceutical products, namely 68-Ga products for use in medicine for third parties, namely advice in relation to radiopharmaceuticals for the therapy and diagnosis of diseases, in particular tumour diseases; advice in relation to radiopharmaceuticals coupled to somatostatin analogues and advice in relation to the manufacture of personalised radiopharmaceutical products containing 68-Ga for use in medicine.

Classification kind code

11

Mark Details

Serial Number

1966025

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 26
on 9th Aug 2024		Approved
Submitted for opposition 27
on 9th Aug 2024		Approval Notice Sent
Submitted for opposition 22
on 20th Mar 2024		Search Recorded
Submitted for opposition 20
on 20th Mar 2024		Examiner's First Report
Submitted for opposition 287
on 31st May 2022		Pre-Assessment Letter Sent
Submitted for opposition 48
on 7th Jan 2022		Agent Changed
Submitted for opposition 135
on 4th Aug 2020		Amendment to Application
Submitted for opposition 31
on 3rd Jun 2019		Formalized
Submitted for opposition 1
on 31st May 2019		Created
Submitted for opposition 30
on 30th May 2019		Filed